Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $531.87 million. The enterprise value is $440.83 million.

Market Cap	531.87M
Enterprise Value	440.83M

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

CMPX has 171.57 million shares outstanding. The number of shares has increased by 4.28% in one year.

Current Share Class	171.57M
Shares Outstanding	171.57M
Shares Change (YoY)	+4.28%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	5.48%
Owned by Institutions (%)	39.43%
Float	97.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.60
P/TBV Ratio	5.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.66, with a Debt / Equity ratio of 0.11.

Current Ratio	7.66
Quick Ratio	7.28
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.84% and return on invested capital (ROIC) is -33.88%.

Return on Equity (ROE)	-51.84%
Return on Assets (ROA)	-31.14%
Return on Invested Capital (ROIC)	-33.88%
Return on Capital Employed (ROCE)	-65.97%
Revenue Per Employee	n/a
Profits Per Employee	-$1.77M
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +174.34% in the last 52 weeks. The beta is 1.30, so CMPX's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+174.34%
50-Day Moving Average	2.76
200-Day Moving Average	2.27
Relative Strength Index (RSI)	54.98
Average Volume (20 Days)	1,213,958

Short Selling Information

The latest short interest is 8.11 million, so 4.73% of the outstanding shares have been sold short.

Short Interest	8.11M
Short Previous Month	7.84M
Short % of Shares Out	4.73%
Short % of Float	8.33%
Short Ratio (days to cover)	11.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-67.84M
Pretax Income	-47.24M
Net Income	-62.03M
EBITDA	-67.32M
EBIT	-67.84M
Earnings Per Share (EPS)	-$0.45

Full Income Statement

Balance Sheet

The company has $100.95 million in cash and $9.90 million in debt, giving a net cash position of $91.05 million or $0.53 per share.

Cash & Cash Equivalents	100.95M
Total Debt	9.90M
Net Cash	91.05M
Net Cash Per Share	$0.53
Equity (Book Value)	93.21M
Book Value Per Share	0.67
Working Capital	92.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.25 million and capital expenditures -$62,000, giving a free cash flow of -$45.32 million.

Operating Cash Flow	-45.25M
Capital Expenditures	-62,000
Free Cash Flow	-45.32M
FCF Per Share	-$0.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.28%
Shareholder Yield	-4.28%
Earnings Yield	-11.66%
FCF Yield	-8.52%

Analyst Forecast

The average price target for CMPX is $13.50, which is 335.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	335.48%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	240.94%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CMPX has an Altman Z-Score of 0.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.89
Piotroski F-Score	1